CCNE1 and cancer: Significantly, cancers with FBW7 mutations have increased levels of cyclin E. Furthermore, protein phosphatases, such as PP2A-B56, dephosphorylate Ser384 during the interphase of the cell cycle, resulting in a decrease in FBW7 levels and increase in cyclin E levels (15).